Logo image of ULY

URGENT.LY INC (ULY) Stock Fundamental Analysis

USA - NASDAQ:ULY - US9169312074 - Common Stock

3.18 USD
-0.07 (-2.15%)
Last: 10/16/2025, 8:19:09 PM
3.13 USD
-0.05 (-1.57%)
After Hours: 10/16/2025, 8:19:09 PM
Fundamental Rating

2

ULY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. ULY may be in some trouble as it scores bad on both profitability and health. ULY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ULY has reported negative net income.
ULY had a negative operating cash flow in the past year.
In the past 5 years ULY reported 4 times negative net income.
In the past 5 years ULY always reported negative operating cash flow.
ULY Yearly Net Income VS EBIT VS OCF VS FCFULY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

The Return On Assets of ULY (-75.81%) is worse than 88.65% of its industry peers.
Industry RankSector Rank
ROA -75.81%
ROE N/A
ROIC N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ULY Yearly ROA, ROE, ROICULY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

Looking at the Gross Margin, with a value of 23.47%, ULY is doing worse than 78.72% of the companies in the same industry.
In the last couple of years the Gross Margin of ULY has declined.
The Profit Margin and Operating Margin are not available for ULY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
ULY Yearly Profit, Operating, Gross MarginsULY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

1

2. Health

2.1 Basic Checks

ULY does not have a ROIC to compare to the WACC, probably because it is not profitable.
ULY has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ULY has less shares outstanding
ULY has a worse debt/assets ratio than last year.
ULY Yearly Shares OutstandingULY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ULY Yearly Total Debt VS Total AssetsULY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -5.33, we must say that ULY is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ULY (-5.33) is worse than 83.69% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.33
ROIC/WACCN/A
WACC9.62%
ULY Yearly LT Debt VS Equity VS FCFULY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 0.92 indicates that ULY may have some problems paying its short term obligations.
ULY's Current ratio of 0.92 is on the low side compared to the rest of the industry. ULY is outperformed by 75.89% of its industry peers.
ULY has a Quick Ratio of 0.92. This is a bad value and indicates that ULY is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.92, ULY is not doing good in the industry: 75.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
ULY Yearly Current Assets VS Current LiabilitesULY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ULY have decreased strongly by -141.17% in the last year.
The Revenue for ULY has decreased by -20.81% in the past year. This is quite bad
ULY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 305.71% yearly.
EPS 1Y (TTM)-141.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.9%
Revenue 1Y (TTM)-20.81%
Revenue growth 3Y336.36%
Revenue growth 5Y305.71%
Sales Q2Q%-8.25%

3.2 Future

The Earnings Per Share is expected to grow by 21.74% on average over the next years. This is a very strong growth
ULY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.35% yearly.
EPS Next Y62.42%
EPS Next 2Y36.79%
EPS Next 3Y27.63%
EPS Next 5Y21.74%
Revenue Next Year-10.4%
Revenue Next 2Y3.79%
Revenue Next 3Y8.35%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ULY Yearly Revenue VS EstimatesULY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ULY Yearly EPS VS EstimatesULY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ULY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ULY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ULY Price Earnings VS Forward Price EarningsULY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ULY Per share dataULY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as ULY's earnings are expected to grow with 27.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.79%
EPS Next 3Y27.63%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ULY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

URGENT.LY INC

NASDAQ:ULY (10/16/2025, 8:19:09 PM)

After market: 3.13 -0.05 (-1.57%)

3.18

-0.07 (-2.15%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-10 2025-11-10
Inst Owners1.75%
Inst Owner Change0%
Ins Owners6.63%
Ins Owner Change1.44%
Market Cap4.45M
Analysts80
Price Target11.73 (268.87%)
Short Float %6.22%
Short Ratio1.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-65.36%
Min EPS beat(2)-65.7%
Max EPS beat(2)-65.02%
EPS beat(4)0
Avg EPS beat(4)-66.92%
Min EPS beat(4)-121.92%
Max EPS beat(4)-15.03%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.44%
Max Revenue beat(2)1.2%
Revenue beat(4)2
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)1.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-128.09%
EPS NY rev (1m)-4.92%
EPS NY rev (3m)-54.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-26.6
EYN/A
EPS(NY)-4.68
Fwd EYN/A
FCF(TTM)-13.97
FCFYN/A
OCF(TTM)-9.18
OCFYN/A
SpS93.74
BVpS-29.51
TBVpS-36.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.47%
FCFM N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
F-Score4
Asset Turnover3.27
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.07%
Cap/Sales 5.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z -5.33
F-Score4
WACC9.62%
ROIC/WACCN/A
Cap/Depr(3y)54.32%
Cap/Depr(5y)95.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)25.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.9%
EPS Next Y62.42%
EPS Next 2Y36.79%
EPS Next 3Y27.63%
EPS Next 5Y21.74%
Revenue 1Y (TTM)-20.81%
Revenue growth 3Y336.36%
Revenue growth 5Y305.71%
Sales Q2Q%-8.25%
Revenue Next Year-10.4%
Revenue Next 2Y3.79%
Revenue Next 3Y8.35%
Revenue Next 5YN/A
EBIT growth 1Y67.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.25%
EBIT Next 3Y35.07%
EBIT Next 5YN/A
FCF growth 1Y49.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.49%
OCF growth 3YN/A
OCF growth 5YN/A